Q1 FY26 Consolidated Revenues grew 15% YoY to Rs. 5,842 Crore
Q1 FY26 Consolidated EBITDA grew 26% YoY to Rs. 852 Crore
Q1 FY26 Consolidated PAT grew 42% YoY to Rs. 433 Crore
During the quarter, AHEL also announced de-merger of its Omni Channel Pharmacy and Digital Health business into a new entity Apollo Healthtech Ltd. to unlock value for existing shareholders
Apollo Children’s Hospitals achieved a milestone of completing 6,000 pediatric cardiac surgeries
Launched ‘OraLife’ for the early detection of oral cancer with the intention to raise awareness and utilizes AI-powered technology for diagnosing the disease
Unveiled Apollo Zen – the most clinically advanced health management program, powered by advanced diagnostics and AI insights for preventive care
Announced expansion of 700 beds in 2 phases in Bengaluru; will take total bed capacity to 1,500 beds
On track to add 4,370 beds through acquisition, brownfield and greenfield expansion over the next 3-4 years
Dr. Prathap C Reddy, Chairman, Apollo Hospitals Enterprise Ltd. said, “I am proud to see the resilient comeback in the first quarter of FY26, building on the strong foundation of Q4FY25. I am glad to inform you that Q1FY26 has delivered another robust set of results, with revenue growth in the double digits at 15% YoY and continued improvement in margins. Our performance demonstrates the power and resilience of our integrated model of healthcare delivery with all three engines – our core divisions, Healthcare Services, Retail Healthcare & Diagnostics, and Digital & Pharma Distribution, contributing to our performance.
Patient numbers across our network increased year-on-year, reflecting both the deeper penetration of our Centers of Excellence and the growing confidence of communities in our integrated care model. The quarter saw us announce our ambitious growth strategy to add over 4,300 beds in the next five years with an investment of over ₹7,600 crore. The first phase of 2,000 beds is already in progress. We have added an existing 200-bed hospital in Bengaluru and will also be establishing a 500-bed greenfield hospital in the suburbs of the city to bring the total bed strength in Bengaluru to 1,500 beds. In Hyderabad, we are adding 160 beds at our existing Jubilee Hills and Secunderabad facilities, and with the upcoming facility in Gachibowli, our bed strength in the city will increase to 1,400 beds.
On the digital front, Apollo 24|7 achieved a quarterly GMV of over Rs. 682 crore, sustaining the platform’s momentum and signaling the continuing strong demand for teleconsultations, lab and pharmacy deliveries. This performance builds on the platform’s FY25 GMV of Rs. 3,007 crore, demonstrating our success in creating a seamless care continuum from home to hospital.
The demerger of our digital health and pharmacy business, approved in the last quarter, is now in the implementation phase. This strategic move will enable focused capital allocation and sharper growth plans with dedicated management teams for both hospital operations and omnichannel healthcare ecosystem, a structure designed to maximize synergies while preserving the Apollo ethos of quality and trust.
Preventive healthcare remains at the heart of our mission. Through the AI-based Apollo ProHealth platform, we have crossed 2.5Million health assessments this quarter alone, guiding individuals on personalized wellness journeys and strengthening early -detection pathways.
Patient access continues to guide our investments. We expanded our ‘Care-Within-Reach’ financing programs to additional tier2 and tier3 markets, ensuring that advanced treatments remain accessible to a broad segment of the population. Our efforts on sustainability saw us launch ‘Green Health’ initiatives in Mumbai and Hyderabad, achieving a 20% reduction in energy consumption per patient day and using ecofriendly materials across new construction projects.
Looking ahead, we anticipate continued double digit revenue growth for FY26, underpinned by new hospital openings in Patna and Jaipur slated for Q3, further digital innovation, and deepening partnerships with state governments to bolster community-based health initiatives. I remain confident that Apollo will set new benchmarks in clinical excellence, patient experience, and sustainable growth—true to our founding mission of enabling healthier, happier lives for all.”
